Great West Life Assurance CO Xenon Pharmaceuticals Inc. Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 15,911 shares of XENE stock, worth $559,589. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,911
Previous 15,911
-0.0%
Holding current value
$559,589
Previous $628,000
0.8%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
70.4MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$199 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$159 Million1.73% of portfolio
-
Wellington Management Group LLP Boston, MA3.78MShares$133 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$102 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$101 Million0.06% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.19B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...